Involvement of immune mechanism in the progressive brain damage

N. Ogawa, Masato Asanuma, Y. Kondo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

No definitive evidence for the participation of the immune system in progressive brain damage has been previously reported. However, glial cells continue to accumulate after degeneration of neurons appears to be completed, and a recent study showed that microglia and leukocytes also accumulate after brain damage. Thus, it seemed possible that immune responses might play a role in the delayed effects. Cyclosporin A (CsA) is a cyclic undecapeptide of fungal origin with a strong immunosuppressive action but low myelotoxicity. We examined the effect of CsA administration on three different kinds of animal models for neurological deficits. Late onset reduction of muscarinic receptors after transient forebrain ischemia in gerbils was prevented by daily post-ischemic administration of CsA. This indicates that an immune mechanism may be involved in the progressive brain damage occurring after transient ischemia. On the other hand, CsA exacerbated iminodipropionitrile-induced dyskinesia both behaviorally and biochemically. CsA also mimicked pentylenetetrazol-induced seizures. These findings suggest that immune mechanisms may play important roles in the progression of brain damage and possibly that immunosuppressants might open a new chapter in the pathophysiology and treatment of chronic progressive neurodegenerative diseases. Further investigations on the immnne response in the progressive brain damage are needed.

Original languageEnglish
Pages (from-to)377-381
Number of pages5
JournalJapanese Journal of Psychopharmacology
Volume14
Issue number5
Publication statusPublished - 1994

Fingerprint

Cyclosporine
Brain
Immunosuppressive Agents
Ischemia
Nerve Degeneration
Pentylenetetrazole
Gerbillinae
Dyskinesias
Microglia
Muscarinic Receptors
Prosencephalon
Neuroglia
Neurodegenerative Diseases
Immune System
Seizures
Leukocytes
Animal Models

Keywords

  • cyclosporin A
  • glial cells
  • iminodipropionitrile
  • late onset reduction of muscarinic receptors
  • pentylenetetrazol

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Involvement of immune mechanism in the progressive brain damage. / Ogawa, N.; Asanuma, Masato; Kondo, Y.

In: Japanese Journal of Psychopharmacology, Vol. 14, No. 5, 1994, p. 377-381.

Research output: Contribution to journalArticle

@article{bd8187f089454cb99dcd9e71c0c00f59,
title = "Involvement of immune mechanism in the progressive brain damage",
abstract = "No definitive evidence for the participation of the immune system in progressive brain damage has been previously reported. However, glial cells continue to accumulate after degeneration of neurons appears to be completed, and a recent study showed that microglia and leukocytes also accumulate after brain damage. Thus, it seemed possible that immune responses might play a role in the delayed effects. Cyclosporin A (CsA) is a cyclic undecapeptide of fungal origin with a strong immunosuppressive action but low myelotoxicity. We examined the effect of CsA administration on three different kinds of animal models for neurological deficits. Late onset reduction of muscarinic receptors after transient forebrain ischemia in gerbils was prevented by daily post-ischemic administration of CsA. This indicates that an immune mechanism may be involved in the progressive brain damage occurring after transient ischemia. On the other hand, CsA exacerbated iminodipropionitrile-induced dyskinesia both behaviorally and biochemically. CsA also mimicked pentylenetetrazol-induced seizures. These findings suggest that immune mechanisms may play important roles in the progression of brain damage and possibly that immunosuppressants might open a new chapter in the pathophysiology and treatment of chronic progressive neurodegenerative diseases. Further investigations on the immnne response in the progressive brain damage are needed.",
keywords = "cyclosporin A, glial cells, iminodipropionitrile, late onset reduction of muscarinic receptors, pentylenetetrazol",
author = "N. Ogawa and Masato Asanuma and Y. Kondo",
year = "1994",
language = "English",
volume = "14",
pages = "377--381",
journal = "Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology",
issn = "1340-2544",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Involvement of immune mechanism in the progressive brain damage

AU - Ogawa, N.

AU - Asanuma, Masato

AU - Kondo, Y.

PY - 1994

Y1 - 1994

N2 - No definitive evidence for the participation of the immune system in progressive brain damage has been previously reported. However, glial cells continue to accumulate after degeneration of neurons appears to be completed, and a recent study showed that microglia and leukocytes also accumulate after brain damage. Thus, it seemed possible that immune responses might play a role in the delayed effects. Cyclosporin A (CsA) is a cyclic undecapeptide of fungal origin with a strong immunosuppressive action but low myelotoxicity. We examined the effect of CsA administration on three different kinds of animal models for neurological deficits. Late onset reduction of muscarinic receptors after transient forebrain ischemia in gerbils was prevented by daily post-ischemic administration of CsA. This indicates that an immune mechanism may be involved in the progressive brain damage occurring after transient ischemia. On the other hand, CsA exacerbated iminodipropionitrile-induced dyskinesia both behaviorally and biochemically. CsA also mimicked pentylenetetrazol-induced seizures. These findings suggest that immune mechanisms may play important roles in the progression of brain damage and possibly that immunosuppressants might open a new chapter in the pathophysiology and treatment of chronic progressive neurodegenerative diseases. Further investigations on the immnne response in the progressive brain damage are needed.

AB - No definitive evidence for the participation of the immune system in progressive brain damage has been previously reported. However, glial cells continue to accumulate after degeneration of neurons appears to be completed, and a recent study showed that microglia and leukocytes also accumulate after brain damage. Thus, it seemed possible that immune responses might play a role in the delayed effects. Cyclosporin A (CsA) is a cyclic undecapeptide of fungal origin with a strong immunosuppressive action but low myelotoxicity. We examined the effect of CsA administration on three different kinds of animal models for neurological deficits. Late onset reduction of muscarinic receptors after transient forebrain ischemia in gerbils was prevented by daily post-ischemic administration of CsA. This indicates that an immune mechanism may be involved in the progressive brain damage occurring after transient ischemia. On the other hand, CsA exacerbated iminodipropionitrile-induced dyskinesia both behaviorally and biochemically. CsA also mimicked pentylenetetrazol-induced seizures. These findings suggest that immune mechanisms may play important roles in the progression of brain damage and possibly that immunosuppressants might open a new chapter in the pathophysiology and treatment of chronic progressive neurodegenerative diseases. Further investigations on the immnne response in the progressive brain damage are needed.

KW - cyclosporin A

KW - glial cells

KW - iminodipropionitrile

KW - late onset reduction of muscarinic receptors

KW - pentylenetetrazol

UR - http://www.scopus.com/inward/record.url?scp=0028080370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028080370&partnerID=8YFLogxK

M3 - Article

C2 - 7856334

AN - SCOPUS:0028080370

VL - 14

SP - 377

EP - 381

JO - Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology

JF - Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology

SN - 1340-2544

IS - 5

ER -